Session » (0001–0008) B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster
- 9:00AM-11:00AM
-
Abstract Number: 0004
CD22 X CD79b Bispecific Ab Potently Inhibits B Cell Activation and Plasmablast Accumulation
- 9:00AM-11:00AM
-
Abstract Number: 0008
Differential Induction of Anti-Muscarinic Type-3-Receptor Antibodies by Immunization with 4-Hydroxy-2-nonenal-Modified Ro60 in BALB/c Mice
- 9:00AM-11:00AM
-
Abstract Number: 0003
Expanded Extrafollicular B Cells Were Improved by RTX in IgG4-related Disease
- 9:00AM-11:00AM
-
Abstract Number: 0001
Loss of the Complement Regulator CD55 Alters Marginal Zone B Cell Homeostasis
- 9:00AM-11:00AM
-
Abstract Number: 0005
Obexelimab Inhibits B Cell Activation and May Interfere with B Cell Chemotaxis in IgG4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 0002
Population Pharmacokinetic and Pharmacodynamic Analyses of Obexelimab in Healthy Volunteers and in Patients with Rheumatoid Arthritis or IgG4-Related Diseases
- 9:00AM-11:00AM
-
Abstract Number: 0006
Preclinical Characterization of a Novel anti-CD40 Antagonist Antibody-glucocorticoid Conjugate with Superior Preclinical Efficacy and Favorable Safety Profile
- 9:00AM-11:00AM
-
Abstract Number: 0007
Targeting NF-κB Signalling in B Cells from ANCA-associated Vasculitis Impairs B Cell Biology as a Potential Novel Target